Genestra Brands PhosCholine Complex
Natural health product licensed in Canada
- Licence holder
- Seroyal International
- NPN or DIN-HM
- 80080523
- Status
- Active licence
- Licence date
- 10 October 2017
- Revision date
- 23 October 2017
- Form
- Comprimé, libération retardée
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boswellia serrata Source : Gum oleoresin Extract : Matériel brut sec Extraction ratio : 16:1 Dry plant equivalent : 400 mg Potency : 20 % 3-Acetyl-11-keto-beta-boswellic acid | 25 mg | Not calculated |
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcuma longa - rhizome | 50 mg | Not calculated |
| Phosphatidylcholine Source : Glycine max - Graine | 187.5 mg | Not calculated |
Non-medicinal ingredients
Éthylcellulose, Cellulose, Acide stéarique, Silice, Alginate de sodium, Hyprolose, Palmitate d'ascorbyle, Croscarmellose de sodium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | 4 Tous les jours |
Uses authorised in Canada
Temporarily improves joint function in mild to moderate osteoarthritis of the knee. Temporarily relieves the pain of mild to moderate osteoarthritis of the knee in as little as five days. Helps to relieve joint pain and swelling associated with mild to moderate osteoarthritis of the knee. Phosphatidylcholine, a source of choline, helps supports liver function. Phosphatidylcholine, a source of choline, is a factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding, have gallstones or a bile duct obstruction, have stomach ulcers or excess stomach acid, or taking antiplatelet medication or blood thinners. Consult a healthcare practitioner if symptoms worsen.
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use.
Source
Official Health Canada record, licence 80080523
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging